The Policy Action Network on Diabetes - ExPAND - is a policy and advocacy programme led by IDF Europe.
Established in 2012, ExPAND gathers together a group of National Parliamentarians, Members of the European Parliament, leading diabetes organizations and experts from across Europe. Their aim is to act as a strong pan-European forum to drive a new generation of policies to address the diabetes epidemic.
While there are many partnerships between associations of people with diabetes, healthcare professionals, health ministers and other key stakeholders, the Policy Action Network on Diabetes is the first initiative of its kind in Europe. Its goal is to build a strong network of parliamentarians to act on diabetes at local, national and European levels.
The Policy Action Network on Diabetes is chaired by Adrian Sanders MP (UK).
Members include Teresa Caeiro MP (Portugal), Czeslaw Czechyra MP (Poland), Gagik Galstyan MP (Russia), Martin Gregora MP (Czech Republic) and Georgios Papanikoalou MEP (Greece). There is also strong representation from diabetes associations from across the European region including Spain, Italy and Romania.
To view a complete list of ExPAND members, click here.
If you are a Member of a Parliament or other national assembly and would like to join the Policy Action Network on Diabetes, or have more information about its work, contact us at firstname.lastname@example.org
The ExPAND Policy Toolkit
As part of its aim to encourage policy action on diabetes, the ExPAND network published a Policy Toolkit. The toolkit provides a one-stop resource covering the economic case for investment in diabetes, evidence of what works, and best practice from across Europe and practical steps for leading and developing new diabetes policies fit for purpose. Key topics include prevention, self-management, innovation and person-centred care. There are also dedicated chapters to care and treatment of children and older people with diabetes.
Click here to download the toolkit.
IDF Europe would like to thank Eli Lilly, Janssen Pharmaceutica, Merck Sharp & Dohme, Roche Diagnostics, Sanofi and particularly AstraZeneca for their support for the ExPAND network.